Status:
COMPLETED
Botulinum Toxin to Improve Cosmesis of Primary Cleft Lip Repair
Lead Sponsor:
The University of Texas Health Science Center, Houston
Conditions:
Cleft Lip
Scarring
Eligibility:
All Genders
Up to 6 years
Phase:
PHASE1
PHASE2
Brief Summary
Objective: To determine if the use of botulinum toxin during primary cleft lip repair improves the cosmetic appearance of the cleft lip scar
Eligibility Criteria
Inclusion
- complete unilateral cleft lip with or without cleft palate
- planned for a primary cleft lip repair
Exclusion
- bilateral cleft lip
Key Trial Info
Start Date :
December 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 13 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT02247193
Start Date
December 1 2015
End Date
January 13 2020
Last Update
November 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Hermann Hospital
Houston, Texas, United States, 77030